Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Rylo Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rylo Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 158 · Grade C

Rylo Health

Visit Rylo Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Rylo Health a bad call — it's best for readers who want straightforward medication and supplies pricing and can resolve the membership and refund-cutoff questions before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
75
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
75
Track Record
88
75
CoreAge RxBrief Score 94 · 71Rylo Health

Price, coverage & the tracker

CoreAge RxRylo Health
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the complete charge

Advertises $139 monthly or $299 quarterly. Separate-service wording conflicts with the bundled no-membership offer.

Full price details

Compounded semaglutide offered; complete quote unknown because membership terms conflict; monthly offer $139 or $299 quarterly; earlier listing: From $149/mo (promotional rate, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the complete charge

Advertises $229 monthly or $479 quarterly. Separate-service wording conflicts with the bundled no-membership offer.

Full price details

Compounded tirzepatide offered; complete quote unknown because membership terms conflict; monthly offer $229 or $479 quarterly; earlier listing: From $249/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises access in all 50 states; confirm individual clinical and pharmacy eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Rylo Health: Public monthly options are $139 semaglutide/$229 tirzepatide; quarterly totals $299/$479. Membership wording prevents confirming the complete bill.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.